Overview

Isovue in Peripheral Digital Subtraction Angiography (DSA)

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
No significant differences is expected in observed motion artifacts, heat or pain reported during peripheral DSA performed for diagnostic and/or endovascular therapeutic purposes.
Phase:
Phase 4
Details
Lead Sponsor:
Bracco Diagnostics, Inc